Thursday, July 16, 2015, an oft-stated, but rarely occurring, meeting will be held. If you can get there, I hope to see you in attendance. Continue Reading
June 12, 2015
News: Sequenom’s patent invalidated, Ron Burgundy commentary, & informed consent concerns raised
From the News page, some significant developments concerning cell free DNA, with commentary by Anchorman Ron Burgundy: Continue Reading
May 13, 2015
ISPD: not that serious of a concern after all
Over at the Prenatal Information Research Consortium (PIRC) blog I have a post noting the "sea-change" in the International Society for Prenatal Diagnosis' position on noninvasive prenatal screening. Here are a few other notes from the ISPD's updated statement on NIPS. Continue Reading
December 20, 2013
The new era of Down syndrome prenatal testing
The newest prenatal testing recommendation now adds microarray testing to the options available for expectant moms. But how does this apply specifically to prenatal testing for Down syndrome? Continue Reading
April 15, 2013
Is the ISPD statement unjustified?
Continuing the series of posts on the new International Society for Prenatal Diagnosis's (ISPD) policy statement on prenatal testing for aneuploidy, I will seek to answer the questions prompted by that statement. In doing so, it leads to the ultimate question of whether the ISPD statement is unjustified? Continue Reading
April 11, 2013
Does the ISPD have its own version of Voldemort?
The International Society for Prenatal Diagnosis (ISPD) has issued a new position statement on prenatal testing for Down syndrome. I have reported on what the statement says in the past several posts. Now, we turn a critical eye to the statement to provide an ethical assessment of it. What is most glaring is what is not stated in the new statement. I wonder if the ISPD has it's own version of Voldemort. Continue Reading
April 9, 2013
The ISPD has a serious concern about new prenatal testing for Down syndrome
The International Society for Prenatal Diagnosis (ISPD) issued a policy statement that sets forth its position on prenatal testing for Down syndrome. The policy statement was prompted by the new prenatal testing for Down syndrome called Non-Invasive Prenatal Screening (NIPS), where a mother's risk assessment is recalculated based on testing cell free DNA in her blood stream. ISPD has a "serious concern" about NIPS. Read on to find out why. Continue Reading
April 8, 2013
What is the optimal prenatal testing protocol for Down syndrome?
Last week, both the American College of Medical Genetics and Genomics and the International Society for Prenatal Diagnosis (ISPD) issued position statements on the latest developments in prenatal testing for Down syndrome. I selected highlights here. In this post, I cover what the ISPD statement claims is "optimal" for prenatal testing for Down syndrome. Continue Reading
Recent Comments